These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 28470084)

  • 21. Detection of alpha- and epsilon-toxigenic Clostridium perfringens type D in sheep and goats using a DNA amplification technique (PCR).
    Miserez R; Frey J; Buogo C; Capaul S; Tontis A; Burnens A; Nicolet J
    Lett Appl Microbiol; 1998 May; 26(5):382-6. PubMed ID: 9674169
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clostridium perfringens epsilon toxin mutant Y30A-Y196A as a recombinant vaccine candidate against enterotoxemia.
    Bokori-Brown M; Hall CA; Vance C; Fernandes da Costa SP; Savva CG; Naylor CE; Cole AR; Basak AK; Moss DS; Titball RW
    Vaccine; 2014 May; 32(23):2682-7. PubMed ID: 24709588
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Toxin typing of
    Hayati M; Tahamtan Y
    Arch Razi Inst; 2021; 76(3):691-697. PubMed ID: 34824761
    [No Abstract]   [Full Text] [Related]  

  • 24. Genetic appraisal of serological response post vaccination against enterotoxaemia (ET) in Malpura and Avikalin sheep.
    Gowane GR; Akram N; Prince LL; Prakash V; Kumar A
    Trop Anim Health Prod; 2017 Apr; 49(4):867-873. PubMed ID: 28337572
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunization of mice against alpha, beta, and epsilon toxins of Clostridium perfringens using recombinant rCpa-b-x expressed by Bacillus subtilis.
    Wang Y; Miao Y; Hu LP; Kai W; Zhu R
    Mol Immunol; 2020 Jul; 123():88-96. PubMed ID: 32447084
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A low-toxic site-directed mutant of Clostridium perfringens ε-toxin as a potential candidate vaccine against enterotoxemia.
    Li Q; Xin W; Gao S; Kang L; Wang J
    Hum Vaccin Immunother; 2013 Nov; 9(11):2386-92. PubMed ID: 23835363
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clostridium perfringens type-D enterotoxaemia in cattle: the diagnostic significance of intestinal epsilon toxin.
    Jones AL; Dagleish MP; Caldow GL
    Vet Rec; 2015 Oct; 177(15):390. PubMed ID: 26428898
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of different fluids for detection of Clostridium perfringens type D epsilon toxin in sheep with experimental enterotoxemia.
    Layana JE; Fernandez Miyakawa ME; Uzal FA
    Anaerobe; 2006 Aug; 12(4):204-6. PubMed ID: 16857397
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An EGFP-marked recombinant lactobacillus oral tetravalent vaccine constitutively expressing α, ε, β1, and β2 toxoids for
    Ding G; Bai J; Feng B; Wang L; Qiao X; Zhou H; Jiang Y; Cui W; Tang L; Li Y; Xu Y
    Virulence; 2019 Dec; 10(1):754-767. PubMed ID: 31429624
    [No Abstract]   [Full Text] [Related]  

  • 30. Antibody responses of mares to prepartum vaccination with Clostridium perfringens bacterin and beta2 toxin.
    Timoney JF; Hartmann M; Fallon L; Fallon E; Walker J
    Vet Rec; 2005 Dec; 157(25):810-2. PubMed ID: 16361475
    [No Abstract]   [Full Text] [Related]  

  • 31. The standardization of Cl. perfringens antigens and antisera.
    Jansen BC
    Dev Biol Stand; 1976; 32():35-44. PubMed ID: 187510
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The early effects of Clostridium perfringens type D epsilon toxin in ligated intestinal loops of goats and sheep.
    Fernandez Miyakawa ME; Uzal FA
    Vet Res Commun; 2003 Apr; 27(3):231-41. PubMed ID: 12777097
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Naturally acquired antibodies against Clostridium perfringens epsilon toxin in goats.
    Veschi JL; Bruzzone OA; Losada-Eaton DM; Dutra IS; Fernandez-Miyakawa ME
    Vet Immunol Immunopathol; 2008 Sep; 125(1-2):198-202. PubMed ID: 18538416
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ANTIBODY RESPONSE TO EPSILON TOXIN OF CLOSTRIDIUM PERFRINGENS IN CAPTIVE RED DEER (CERVUS ELAPHUS) OVER A 13-MONTH PERIOD.
    Scala C; Duffard N; Beauchamp G; Boullier S; Locatelli Y
    J Zoo Wildl Med; 2016 Mar; 47(1):38-44. PubMed ID: 27010263
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinicopathological and immunological studies on toxoids vaccine as a successful alternative in controlling clostridial infection in broilers.
    Saleh N; Fathalla SI; Nabil R; Mosaad AA
    Anaerobe; 2011 Dec; 17(6):426-30. PubMed ID: 21664285
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enzyme linked immunosorbent assay for potency testing of vaccines containing Clostridium perfringens type D epsilon-toxoid.
    Pfahler W; Bisesti E; Pereyra JB; Iribarren F
    Zentralbl Veterinarmed B; 1998 Apr; 45(3):133-9. PubMed ID: 9588107
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A simple method for purification of epsilon toxin of Clostridium perfringens type D for serum neutralization assay.
    Abdolmohammadi Khiav L; Emadi A; Zahmatkesh A
    J Microbiol Methods; 2022 Feb; 193():106395. PubMed ID: 34921869
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The prevention of enterotoxaemia (pulpy kidney disease) by vaccination.
    Jansen BC
    Bull Off Int Epizoot; 1967; 67(11):1539-67. PubMed ID: 4309687
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparison of humoral neutralizing antibody response in rabbits, guinea pigs, and cattle vaccinated with epsilon and beta toxoids from Clostridium perfringens and C. botulinum types C and D toxoids.
    Silva ROS; Duarte MC; Oliveira Junior CA; de Assis RA; Lana AMQ; Lobato FCF
    Anaerobe; 2018 Dec; 54():19-22. PubMed ID: 30076896
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A non-toxic recombinant bivalent chimeric protein rETX
    Du J; Liu B; Wang T; Zhu Z; Yin C; Luo Y; Liu Y; Chen X
    Vaccine; 2023 Feb; 41(6):1232-1238. PubMed ID: 36635138
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.